Drug intelligence / Profile preview

PIPA solution

Development stage
Preclinical
Lead developer
Citra Labs
Modality
Small Molecules
Administration
Parenteral
01

Overview

PIPA solution is a sterile red blood cell rejuvenation processing solution containing sodium pyruvate, inosine, adenine, dibasic sodium phosphate, and monobasic sodium phosphate. The marketed U.S. product is **Rejuvesol**, which is used only extracorporeally: stored red blood cell units are incubated with the solution before washing and transfusion. Its metabolic substrates replenish erythrocyte ATP and 2,3-diphosphoglycerate, helping reverse storage-associated metabolic loss and restore oxygen-release capacity. It is not intended for direct injection into patients. ([dailymed.nlm.nih.gov](https://dailymed.nlm.nih.gov/dailymed/fda/fdaDrugXsl.cfm?setid=bc06c40f-81a0-45e5-80b6-61f67d445068))

Brand names
Rejuvesol
Other names
phosphate + inosine + pyruvate + adenine solutionpyruvate + inosine + phosphate + adenine solutionpyruvate-inosine-phosphate-adenine solution
02

Targets

CAMK2A (Calcium/calmodulin-dependent protein kinase II alpha)

Beyond the preview

Go deeper on PIPA solution.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on PIPA solution.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call